744 Results

People

  1. Levine
    Levine
  2. Abdel-Wahab
    Abdel-Wahab
  3. Tallman
    Tallman
  4. Rampal
    Rampal
  5. Patel
    Patel
  6. Shih
    Shih
  7. Famulare
    Famulare
  8. Stein
    Stein
  9. Patel
    Patel
  10. Devlin
    Devlin

Groups

  1. Adult Leukemia (744)
  2. Center for Hematologic Malignancies (744)
  3. Department of Medicine (744)
  4. Executive Committee, Center for Hematologic Malignancies (744)
  5. GSK Faculty (744)
  6. Hematologic Malignancies, Division of (744)
  7. Human Oncology and Pathogenesis Program (744)
  8. Tow Center for Developmental Oncology (TCDO) (236)
  9. Sloan Kettering Institute Postdocs (198)
  10. Epidemiology and Biostatistics (127)
  1. "Ross Levine"
  2. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Journal Article (369)
  2. Meeting Abstract (332)
  3. Editorial (13)
  4. Review (12)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (744)
  2. Center for Hematologic Malignancies (744)
  3. Department of Medicine (744)
  4. Executive Committee, Center for Hematologic Malignancies (744)
  5. GSK Faculty (744)
  6. Hematologic Malignancies, Division of (744)

More Groups

People
  1. Ross Levine (744)
  2. Omar Abdel-Wahab (165)
  3. Martin Tallman (130)
  4. Raajit Rampal (86)
  5. Eytan Stein (63)
  6. Maria Arcila (57)

More People

Years
  1. 2024 (9)
  2. 2023 (45)
  3. 2022 (41)
  4. 2021 (44)
  5. 2020 (58)
  6. 2019 (53)

More Years

Publications
  1. Blood (279)
  2. Leukemia (33)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (20)
  6. Cancer Cell (20)

More Publications

Publishers
  1. American Society of Hematology (301)
  2. Nature Publishing Group (100)
  3. American Association for Cancer Research (64)
  4. Cell Press (46)
  5. Ferrata Storti Foundation (24)
  6. Elsevier Inc. (21)

More Publishers

Results (744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction
    Journal Article

    Amor, C.; Fernández-Maestre, I.; Chowdhury, S.; Ho, Y. J.; Nadella, S.; Graham, C.; Carrasco, S. E.; Nnuji-John, E.; Feucht, J.; Hinterleitner, C.; more...
    Nature Aging (2024)

    Fulltext@MSK | Save
  • FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia
    Journal Article

    Sung, P. J.; Selvam, M.; Riedel, S. S.; Xie, H. M.; Bryant, K.; Manning, B.; Wertheim, G. B.; Kulej, K.; Pham, L.; Bowman, R. L.; more...
    Leukemia (2024)

    Fulltext@MSK | Save
  • High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer
    Journal Article

    Stonestrom, A. J.; Menghrajani, K. N.; Devlin, S. M.; Franch-Expósito, S.; Ptashkin, R. N.; Patel, S. Y.; Spitzer, B.; Wu, X.; Jee, J.; Vela, P. S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
    Research Letter

    Paudel, B. B.; Tan, S. F.; Fox, T. E.; Ung, J.; Golla, U.; Shaw, J. J. P.; Dunton, W.; Lee, I.; Fares, W. A.; Patel, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable
    Journal Article

    Codilupi, T.; Szybinski, J.; Arunasalam, S.; Jungius, S.; Dunbar, A. C.; Stivala, S.; Brkic, S.; Albrecht, C.; Vokalova, L.; Yang, J. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Suppression of IL-1β promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesis
    Journal Article

    Fidler, T. P.; Dunbar, A.; Kim, E.; Hardaway, B.; Pauli, J.; Xue, C.; Abramowicz, S.; Xiao, T.; O'Connor, K.; Sachs, N.; more...
    Nature Cardiovascular Research (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
    Journal Article

    Cai, S. F.; Huang, Y.; Lance, J. R.; Mao, H. C.; Dunbar, A. J.; McNulty, S. N.; Druley, T.; Li, Y.; Baer, M. R.; Stock, W.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms
    Journal Article

    Pritchard, J. E.; Pearce, J. E.; Snoeren, I. A. M.; Fuchs, S. N. R.; Götz, K.; Peisker, F.; Wagner, S.; Benabid, A.; Lutterbach, N.; Klöker, V.; more...
    Cell Reports (2024)

    Fulltext@MSK | Save
  • Influence of pre-treatment features and therapy choice by physicians on overall survival in older adults with acute myeloid leukemia: A report from the beat AML master trial
    Meeting Abstract

    Borate, U. M.; Huang, Y.; Welkie, R. L.; Swords, R. T.; Traer, E.; Stein, E. M.; Lin, T. L.; Madanat, Y. F.; Patel, P. A.; Collins, R. H.; more...
    Blood (2023)

    Fulltext@MSK | Save